Analysis of hematopoietic progenitor cells in patients with myelodysplastic syndromes according to their cytogenetic abnormalities

Leukemia Research
Natalia López-HolgadoM Consuelo Del Cañizo Fernández-Roldán

Abstract

The present work analyzes the hematopoietic progenitor cells (HPC) in myelodysplastic syndrome (MDS) patients using both an immunophenotypical and a functional approaches in order to know whether they are similar in patients with or without cytogenetic abnormalities. Among CD34+ HPC, the proportion of myeloid committed progenitors was higher in patients with an abnormal karyotype. Ninety MDS patients were studied. Patients with abnormal karyotype showed a similar platting efficiency than patients with normal cytogenetics. Trisomy 8 and 5q- showed a significant higher P.E. than patients with normal karyotype or monosomy 7. We observed that when the most immature HPC were studied, the total number of granulo-monocytic colonies produced by LTBMC was higher in the normal karyotype group. In summary, the present study shows that in MDS the HPC are impaired; this impairment is deeper in patients with abnormal karyotype.

Citations

Mar 1, 2008·Journal of Cardiovascular Translational Research·Ricardo Sanz-RuizFrancisco Fernández-Avilés
Dec 15, 2005·Cytometry. Part B, Clinical Cytometry·Alejandro Ruiz-ArgüellesUNKNOWN Latin American Consensus Conference
Jan 7, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Aristoteles A N GiagounidisCarlo Aul

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.